DNA

Ginkgo Bioworks Holdings Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↑ 7/10
  • Value↓ 0/10
Ginkgo Bioworks Holdings sales and earnings growth
DNA Growth
Good
  • Revenue Y/Y↓ -25.06%
  • EPS Y/Y↑ 46.49%
  • FCF Y/Y↑ 53.30%
Ginkgo Bioworks Holdings gross and profit margin trends
DNA Profitability
Low
  • Gross margin ↑ 72.40%
  • EPS margin↓ -183.80%
  • ROIC 5Y↓ -76.78%
Ginkgo Bioworks Holdings net debt vs free cash flow
DNA Risk
Great
  • Debt / Equity↓ 0.8
  • Debt / FCF↓ 1.4
  • Interest coverage↑ 999.0

Ginkgo Bioworks Holdings stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗